Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes.
Martin H LundqvistVagia PatsoukakiStefan JanssonHenrietta NormanElisabet GranstamMaria K SvenssonJohan SundströmBjörn EliassonJan W ErikssonPublished in: Diabetes & vascular disease research (2023)
Microvascular complication variables in the NDR show good agreement with EHR data. The use of a well-established national health care registry, exemplified by the NDR, for endpoint collection in RRCTs such as SMARTEST is supported by this study.